Clinical trial reports

  • Which Endpoints Are Measured Most Often in European Endocrinology Phase 2 & 3 Trials?
  • Which CROs support Phase III lung cancer trials in Europe from 2024 to 2026?
  • Which Endpoints Are Measured Most Often in European Multiple Sclerosis Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Rheumatoid Arthritis Phase II & III Trials?
  • Which Endpoints Are Most Frequently Measured in European Nephrology Phase II & III Trials?
  • Top European Sites in Phase I Cell Therapy Trials
  • Which EU sites anchor Phase II/III endometrial cancer trials?
  • Which CROs Are Most Active in European Diabetes Phase II/III Trials, and Where Is Outsourcing Demand Highest?
  • Which EU sites are most active in ovarian cancer Phase II–III trials?
  • Which Endpoints Are Measured Most Often in European Phase II & III Lymphoma Trials?
  • Which Sites Are Most Active in European Cardiology Phase II–III Trials?
  • Which EU sites are most active in Alzheimer’s phase II and III trials?